PR interval exome chip analysis

Dataset

Download summary statistics | README

Publications

Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval.
Lin H, et al.
Circ Genom Precis Med. 2018;11:e002037. doi: 10.1161/CIRCGEN.117.002037

Dataset phenotypes

  • PR interval duration

Dataset subjects

Subjects Cohort Ancestry
2,052 Age, Gene/Environment Susceptibility Study (AGES) European
3,366 Atherosclerosis Risk in Communities Study (ARIC) African American
9,828 Atherosclerosis Risk in Communities Study (ARIC) European
841 British Genetics of Hypertension (BRIGHT) European
2,493 Cardiology and Metabolic Patient (CAMP) European
627 Cardiovascular Health Study (CHS) African American
3,247 Cardiovascular Health Study (CHS) European
982 Erasmus Rucphen Family Study (ERF) European
7,580 Framingham Heart Study (FHS) European
355 Genes for Cerebral Hemorrhage on Anticoagulation (GOCHA) European
1,755 Genetic Regulation of Arterial Pressure in Humans in the Community (GRAPHIC) European
9,168 Generation Scotland: Scottish Family Health Study (GS:SFHS) European
5,836 INTER99 European
2,220 Jackson Heart Study (JHS) African American
2,617 Cooperative Health Research in the Region Augsburg (KORA) European
293 CROATIA-Korcula (KORCULA) European
1,934 LifeLines Cohort Study (LifeLines) European
1,565 Multi-Ethnic Study of Atherosclerosis (MESA) African American
2,455 Multi-Ethnic Study of Atherosclerosis (MESA) European
5,782 The Netherlands Epidemiology of Obesity (NEO) European
2,358 Rotterdam Study (RS) European
6,493 Study of Health in Pomerania (SHIP) European
465 TwinsUK Registry (TwinsUK) European
1,735 Utrecht Health Project (UHP) European
1,658 Women’s Health Initiative (WHI) African American
13,252 Women’s Health Initiative (WHI) European
1,846 Young Finns Study (YFS) European

Dataset subjects by ancestry

Subjects Ancestry
9,436 African American
83,367 European
92,803 All

Experiment summary

The PR interval exome chip analysis surveyed nearly 93,000 subjects for whom cardiac conduction measurements were available. Subjects were excluded if they exhibited any of the following conditions: extreme PR values (≤80 or ≥320 ms); second- or third-degree heart block; AF on baseline ECG; history of myocardial infarction, heart failure, or Wolff–Parkinson–White syndrome; pacemaker placement; use of class I or III blocking medications (ATC code pre x C01B); digoxin use (ATC code C01AA05); or pregnancy. PR interval duration, in milliseconds, was measured from the onset of the P wave to the onset of the QRS interval for each cohort. Genotyping was performed using the Illumina Human Exome BeadChip (v1.0, 1.1, or 1.2).

Dataset ID
ExChip_EPRI